BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The past few years for the TCR community have been dynamic. Ap
 provals have signalled a viable path to commercialization\, while a wave 
 of company closures highlight the deep-rooted challenges in the current d
 evelopment processes. The message is clear: success is not guaranteed at 
 approval. Addressing manufacturing costs\, durability and long-term comme
 rcial viability is now mission critical for developers of TCR-based cell 
 and biologic therapies.\n\nSpanning the full therapeutic landscape\, incl
 uding TCR-T\, TCR mimetics\, TCR-TCEs and TCR bispecifics\, the 7th TCR-B
 ased Therapies Summit cuts through the noise to focus exclusively on the 
 challenges most acutely impacting the TCR field today. Connect with and h
 ear directly from senior leaders driving progress at the forefront of the
  field\, including C-suite leaders at Immunocore\, Immatics\, T-knife The
 rapeutics\, Anocca\, Zelluna Immunotherapy\, Enara Bio\, Marengo Therapeu
 tics\, and 3T Biosciences.\n\nWith the foundations now in place\, join us
  in empowering the community to shape a more durable\, scalable\, and com
 mercially robust future for TCR-based therapies.\n\nURLs:Website: https:/
 /go.evvnt.com/3452417-0?pid=185Tickets: https://go.evvnt.com/3452417-2?pi
 d=185Brochure: https://go.evvnt.com/3452417-3?pid=185\n\nPrices:Drug Deve
 loper Pricing - Full Access Pass: Conference + Workshop: USD 4397.00\,Dru
 g Developer Pricing - Conference Only: USD 3099.00\,Academic and Not-For 
 Profit Pricing - Full Access Pass: Conference + Workshop: USD 3797.00\,Ac
 ademic and Not-For Profit Pricing - Conference Only: USD 2699.00\,Service
  and Solution Provider Pricing - Full Access Pass: Conference + Workshop:
  USD 5297.00\,Service and Solution Provider Pricing - Conference Only: US
 D 3299.00\n\nSpeakers: Tao Wang\, Associate Professor\, Bioinformatics an
 d Computational Biology\, The University of Texas MD Anderson Cancer Cent
 er\, Cassian Yee\, Director\, T-Cell-Based Therapies (ProTCT)\, Division 
 of Cancer Medicine\, The University of Texas MD Anderson Cancer Center\, 
 Sarah Leonard\, Vice President\, Preclinical Development\, TCR-Based Ther
 apeutics\, T-Cypher Bio\, Mollie Jurewicz\, Director\, TCR and Autoimmune
  Discovery\, TScan Therapeutics\, Emilie Gauthy\, Head\, CMC\, &nbsp\;Zel
 luna Immunotherapy\, David DiLillo\, Senior Director\, Immuno-Oncology\, 
 Regeneron Pharmaceuticals\, Gene Uenishi\, Associate Director\, Discovery
 \, GentiBio\, Ricard Masia\, Senior Director\, Translational Medicine\, C
 rossbow Therapeutics\, Serena Stadler\, Senior Scientist\, Captain T Cell
 \, Qi Zhao\, Principal Scientist\, BioNTech\, Luise Weigand\, Chief Scien
 tific Officer\, Zelluna Immunotherapy\, Annelise Vuidepot\, Chief Technol
 ogy Officer\, Immunocore\, Ke Liu\, Chief Development Officer\, Marengo T
 herapeutics\, Zhen Su\, Chief Executive Officer and Director\, Marengo Th
 erapeutics Inc.\, Rachel Abbott\, Chief Executive Officer\, Pan Cancer T\
 , Peggy Sotiropoulou\, Chief Scientific Officer\, T-knife Therapeutics\, 
 Cedrik Britten\, Chief Medical Officer\, Immatics\, Cheng Liu\, President
  and Chief Executive Officer\, Eureka Therapeutics\, Joseph Dukes\, Chief
  Scientific Officer\, Enara Bio\, Reagan Jarvis\, Chief Executive Officer
  and Co-Founder\, Anocca\, Stefan Scherer\, Chief Executive Officer and P
 resident\, 3T Biosciences\n\nCategory: Conferences | Science\, Health and
  Medicine | Pharmaceuticals\n\nDate and Time: 18th May 2026 at 8:30 am to
  20th May 2026 at 5:00 pm\n\nVenue details: The Colonnade Hotel\, 120 Hun
 tington Avenue\, Boston\, Massachusetts\, 02116\, United States\n
DTEND:20260520T170000
DTSTAMP:20260512T220030Z
DTSTART:20260518T083000
LOCATION:The Colonnade Hotel\, 120\, Huntington Avenue\, Boston\, Massachu
 setts\, 02116\,
SEQUENCE:0
SUMMARY:The past few years for the TCR community have been dynamic. Approv
 als have signalled a viable path to commercialization\, while a wave of c
 ompany cl...
UID:6af38d3e-2b24-4c17-91b2-9bc30e2d14b7
END:VEVENT
END:VCALENDAR